Institutional Ownership
Mira Pharmaceuticals Inc
CUSIP 60458C104COMMIRAQ1 2026
13D / 13G Filings
4
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
32.5%
Max % of class reported
Institutional Holders
23
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
4 filings · latest Dec 27, 2023
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Cross Staff Investments Inc | 359.4K | $384.6K |
| 2 | Geode Capital Management, LLC | 290.9K | $311.3K |
| 3 | Blackrock, Inc. | 112.3K | $120.2K |
| 4 | Suncoast Equity Management | 90.6K | $97.0K |
| 5 | Northern Trust Corp | 67.7K | $72.4K |
| 6 | First American Bank | 60.0K | $64.2K |
| 7 | State Street Corp | 49.1K | $52.5K |
| 8 | Xtx Topco Ltd | 37.6K | $40.2K |
| 9 | Commonwealth Equity Services, LLC | 35.1K | $37.5K |
| 10 | International Assets Investment Management, LLC | 35.0K | $37.1K |